24699859|t|Influence of serum uric acid levels on prognosis and survival in amyotrophic lateral sclerosis: a meta-analysis.
24699859|a|Uric acid (UA) is considered to be one of the most important antioxidants in the blood. While high UA levels are found in many disease states, low UA levels are reported in many neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis (ALS). Various studies showed consistently that ALS patients have lower serum UA levels than healthy individuals, more prominently in cases with bulbar onset and longer disease duration. A systematic search of PubMed was conducted to retrieve published studies on UA levels in ALS patients. A meta-analysis was performed on published studies comparing UA levels between ALS patients and controls. This meta-analysis revealed highly statistically significant (p < 0.0001) lower UA levels and a very large size effect in 311 ALS patients compared to 515 controls as a group, as well as calculated for men and women separately. Many studies indicate that patients with neurodegenerative diseases, including ALS, have low UA levels. Our meta-analysis strengthens these findings in ALS patients, demonstrating highly statistically significant (p < 0.0001) lower UA levels in patients compared to controls, with very large total size effect, more prominent in men.
24699859	19	28	uric acid	Chemical	MESH:D014527
24699859	65	94	amyotrophic lateral sclerosis	Disease	MESH:D000690
24699859	113	122	Uric acid	Chemical	MESH:D014527
24699859	124	126	UA	Chemical	MESH:D014527
24699859	212	214	UA	Chemical	MESH:D014527
24699859	260	262	UA	Chemical	MESH:D014527
24699859	291	317	neurodegenerative diseases	Disease	MESH:D019636
24699859	329	348	Alzheimer's disease	Disease	MESH:D000544
24699859	350	369	Parkinson's disease	Disease	MESH:D010300
24699859	371	389	multiple sclerosis	Disease	MESH:D009103
24699859	395	424	amyotrophic lateral sclerosis	Disease	MESH:D000690
24699859	426	429	ALS	Disease	MESH:D000690
24699859	473	476	ALS	Disease	MESH:D000690
24699859	477	485	patients	Species	9606
24699859	503	505	UA	Chemical	MESH:D014527
24699859	689	691	UA	Chemical	MESH:D014527
24699859	702	705	ALS	Disease	MESH:D000690
24699859	706	714	patients	Species	9606
24699859	777	779	UA	Chemical	MESH:D014527
24699859	795	798	ALS	Disease	MESH:D000690
24699859	799	807	patients	Species	9606
24699859	902	904	UA	Chemical	MESH:D014527
24699859	948	951	ALS	Disease	MESH:D000690
24699859	952	960	patients	Species	9606
24699859	1024	1027	men	Species	9606
24699859	1032	1037	women	Species	9606
24699859	1077	1085	patients	Species	9606
24699859	1091	1117	neurodegenerative diseases	Disease	MESH:D019636
24699859	1129	1132	ALS	Disease	MESH:D000690
24699859	1143	1145	UA	Chemical	MESH:D014527
24699859	1202	1205	ALS	Disease	MESH:D000690
24699859	1206	1214	patients	Species	9606
24699859	1282	1284	UA	Chemical	MESH:D014527
24699859	1295	1303	patients	Species	9606
24699859	1379	1382	men	Species	9606
24699859	Negative_Correlation	MESH:D014527	MESH:D009103
24699859	Negative_Correlation	MESH:D014527	MESH:D000690
24699859	Negative_Correlation	MESH:D014527	MESH:D010300
24699859	Negative_Correlation	MESH:D014527	MESH:D000544
24699859	Negative_Correlation	MESH:D014527	MESH:D019636

